| __timestamp | Amicus Therapeutics, Inc. | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 20717000 | 305409000 |
| Thursday, January 1, 2015 | 47269000 | 377080000 |
| Friday, January 1, 2016 | 71151000 | 432829000 |
| Sunday, January 1, 2017 | 88671000 | 496079000 |
| Monday, January 1, 2018 | 127200000 | 557616000 |
| Tuesday, January 1, 2019 | 169861000 | 658498000 |
| Wednesday, January 1, 2020 | 156407000 | 770456000 |
| Friday, January 1, 2021 | 192710000 | 840100000 |
| Saturday, January 1, 2022 | 213041000 | 944700000 |
| Sunday, January 1, 2023 | 275270000 | 1136600000 |
| Monday, January 1, 2024 | 1464300000 |
Unveiling the hidden dimensions of data
In the competitive world of biotechnology, managing operational costs is crucial for success. Over the past decade, Vertex Pharmaceuticals Incorporated and Amicus Therapeutics, Inc. have demonstrated contrasting strategies in their Selling, General, and Administrative (SG&A) expenses.
From 2014 to 2023, Vertex Pharmaceuticals saw a consistent increase in SG&A expenses, peaking at over $1.1 billion in 2023. This represents a growth of approximately 270% over the period, reflecting their aggressive expansion and investment in administrative capabilities.
In contrast, Amicus Therapeutics' SG&A expenses grew by about 1,230% during the same period, reaching $275 million in 2023. This indicates a more conservative yet significant scaling of their operations.
These trends highlight the diverse strategies employed by biotech firms in managing operational costs, with each approach tailored to their unique business models and growth objectives.
Eli Lilly and Company vs Amicus Therapeutics, Inc.: SG&A Expense Trends
Selling, General, and Administrative Costs: Pfizer Inc. vs Vertex Pharmaceuticals Incorporated
Bristol-Myers Squibb Company or Vertex Pharmaceuticals Incorporated: Who Manages SG&A Costs Better?
Breaking Down SG&A Expenses: Vertex Pharmaceuticals Incorporated vs Zoetis Inc.
Vertex Pharmaceuticals Incorporated and Teva Pharmaceutical Industries Limited: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? Vertex Pharmaceuticals Incorporated or Exelixis, Inc.
Operational Costs Compared: SG&A Analysis of Vertex Pharmaceuticals Incorporated and Opthea Limited
Cost Management Insights: SG&A Expenses for Vertex Pharmaceuticals Incorporated and Ultragenyx Pharmaceutical Inc.
Vertex Pharmaceuticals Incorporated and Amneal Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Selling, General, and Administrative Costs: Vertex Pharmaceuticals Incorporated vs Viridian Therapeutics, Inc.
Alnylam Pharmaceuticals, Inc. and Amicus Therapeutics, Inc.: SG&A Spending Patterns Compared
Selling, General, and Administrative Costs: Amicus Therapeutics, Inc. vs Arrowhead Pharmaceuticals, Inc.